{
  "docId": "019dd923-5ddf-7308-8fca-0e5cf0e1ad99",
  "docSlug": "66e1021b86be5625",
  "documentTitle": "Global pharma winners – focus and efficiency matter",
  "authorId": "RolandBerger",
  "authorName": "Roland Berger",
  "documentKindSlug": "consulting-deck",
  "documentKindLabel": "Consulting deck",
  "sourceTypeSlug": "strategy_consulting",
  "sourceTypeLabel": "Strategy consulting",
  "presentationDate": null,
  "orientation": "portrait",
  "aspectRatio": 0.707,
  "pageNumber": 9,
  "pageCount": 11,
  "prevPage": 8,
  "nextPage": 10,
  "slideType": "diagnosis",
  "function": "diagnose",
  "density": "overcrowded",
  "nDataPoints": 17,
  "notes": "The slide uses a radar chart to visualize a maturity or performance model for pharma companies.",
  "elementsJson": [
    "headline_text",
    "paragraph",
    "radar_chart",
    "bullet_list"
  ],
  "metadataConfidence": 0.95,
  "imagePath": null,
  "slideHref": "/slides/019dd923-5ddf-7308-8fca-0e5cf0e1ad99/9",
  "deckHref": "/decks/019dd923-5ddf-7308-8fca-0e5cf0e1ad99",
  "deckJsonHref": "/decks/019dd923-5ddf-7308-8fca-0e5cf0e1ad99.json",
  "deckAnchorHref": "/decks/019dd923-5ddf-7308-8fca-0e5cf0e1ad99#slide-9",
  "components": [
    {
      "bbox": null,
      "kind": "callout",
      "text": "Our analysis shows that pharma company executives now need to consider the following key questions - and to find solutions to overcoming any potentially identified gaps.",
      "attrs": null,
      "subkind": null,
      "toolName": "Visual emphasis",
      "toolSlug": "visual-emphasis",
      "confidence": null,
      "componentId": "019dd951-e58e-76cb-be47-b3cb38e00c98",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.45,
        "w": 0.38,
        "x": 0.11,
        "y": 0.35
      },
      "kind": "chart",
      "text": "Radar chart showing 17 dimensions across 4 pillars: Business Leadership, Strategic Coherence, Proven Ability to Execute, Size and Financial Position.",
      "attrs": null,
      "subkind": "radar",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "705a231c-a81c-4436-b9b0-a3a87e406f5f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.45,
        "w": 0.38,
        "x": 0.11,
        "y": 0.35
      },
      "kind": "framework",
      "text": "Assessment Grid",
      "attrs": null,
      "subkind": "instance",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "8c023788-f154-4dfd-a0e8-31adf4ce8aed",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.35,
        "x": 0.11,
        "y": 0.87
      },
      "kind": "legend",
      "text": "Largest difference between winners & underperformers; Smallest difference between winners & underperformers",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "11346d4a-ba4c-4fb5-85be-694ee33a5a02",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.35,
        "x": 0.58,
        "y": 0.26
      },
      "kind": "list",
      "text": "Overall: where does my company stand today? Business leadership: is my company a top three player? Strategic coherence: does it display strategic coherence? Proven ability to execute: is it prioritizing resources? Size and financial position: does it have the strength?",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d0796ee0-b898-4bb1-a16f-862b43883fd0",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.38,
        "x": 0.11,
        "y": 0.15
      },
      "kind": "paragraph",
      "text": "Pharma companies should concentrate on the four characteristics that winners have in common. Roland Berger's assessment grid is a powerful tool with which companies can benchmark their business.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c1be6d7b-2454-410c-b34c-b1521afa2d0e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.35,
        "x": 0.58,
        "y": 0.18
      },
      "kind": "paragraph",
      "text": "ESSENTIAL QUESTIONS PHARMA EXECUTIVES NEED TO ANSWER. Our analysis shows that pharma company executives now need to consider the following key questions - and to find solutions to overcoming any potentially identified gaps:",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "fe8bf54f-fc38-4612-b4c4-2d937da69a2e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.3,
        "x": 0.11,
        "y": 0.09
      },
      "kind": "title",
      "text": "Main considerations for pharma executives",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "5fe4d49b-5ed9-456a-8413-fe116739875e",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "maturity-model",
      "slug": null,
      "matchId": "60a38f00-32ee-4910-a9be-d744d64fcda8",
      "evidence": "The radar chart maps 17 dimensions to assess company performance against 'winners'.",
      "confidence": 0.9
    }
  ],
  "arcBeats": [
    {
      "to": 10,
      "from": 9,
      "beatId": "271309e4-eb3d-436f-9b66-ea91610673d4",
      "arcName": "The Consultant's Gambit",
      "arcSlug": "consultants-gambit",
      "beatName": "Impact & Next Steps",
      "beatSlug": "consultants-gambit-impact-next-steps",
      "evidence": "The main considerations for pharma executives and appendix provide impact and next steps",
      "position": 4,
      "confidence": 0.8,
      "parentBeatName": "Resolution",
      "parentBeatSlug": "resolution"
    }
  ],
  "loops": [
    {
      "to": 10,
      "from": 3,
      "name": "Logic Chain",
      "slug": "01-logic-chain",
      "bestFor": "Skeptical audiences, controversial recommendations, rigorous analysis",
      "matchId": "90ec7d40-8102-4183-9181-4f6898343bb0",
      "evidence": "The document provides a clear and logical structure, connecting the situation and context to the solution and approach",
      "position": 0,
      "objective": "To demonstrate the logic and reasoning behind the efficiency measures",
      "structure": "Premise 1 (Accepted truth) -> Premise 2 (Observed fact) -> Therefore... (Inevitable conclusion)",
      "confidence": 0.6,
      "description": "Build an airtight chain of logic where each premise leads inevitably to the conclusion"
    },
    {
      "to": 9,
      "from": 4,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "af7803fc-7fff-46d4-876f-a01233f27297",
      "evidence": "The document emphasizes the importance of efficiency measures in driving strong investor returns",
      "position": 1,
      "objective": "To highlight the cost of inaction and the importance of efficiency measures",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.6,
      "description": "Quantify what happens if the audience does nothing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}